Kienle Breast Cancer.pdf - AnthroMed Library
Kienle Breast Cancer.pdf - AnthroMed Library
Kienle Breast Cancer.pdf - AnthroMed Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 5: Controlled Clinical Studies on VAE Treatment in <strong>Breast</strong> and Gynaecological <strong>Cancer</strong>: Reduction of side effects of chemotherapy, radiation or surgery; QoL (Continued)<br />
Retrolective pharmaco-epidemiological cohort study<br />
<strong>Breast</strong> I–III Conventional<br />
therapy,<br />
Helixor (167)<br />
I–III<br />
I–IV<br />
Conventional<br />
therapy (514)<br />
Conventional<br />
therapy,<br />
Iscador (710)<br />
Conventional<br />
therapy (732)<br />
Conventional<br />
therapy,<br />
Eurixor (219)<br />
Conventional<br />
therapy (470)<br />
Adverse drug reactions ,<br />
Odds ratio: 0.47<br />
95% CI 0.32–<br />
0.67<br />
Odds ratio for occurrence of disease- or treatment<br />
associated symptoms: 0.508<br />
Odds ratio for being symptom-free 3.56 (vomiting,<br />
headache, exhaustion, depression, concentration, sleep,<br />
dizziness, irritability) <br />
Symptom mean score improved (nausea, appetite,<br />
stomach pain, tiredness, depression, concentration,<br />
irritability, sleep)<br />
0.319–0.811 Beuth 2008<br />
[69]<br />
2.03–6.27 Bock 2004<br />
[70]<br />
Change language